Focal dermal hypoplasia

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Classification and external resources
ICD-10 Q82.8
ICD-9 759.89
OMIM 305600
DiseasesDB 29896
eMedicine derm/155
MeSH D005489
GeneReviews

Focal dermal hypoplasia (also known as "Goltz syndrome") is a form of ectodermal dysplasia.[1] It is a multisystem disorder characterized primarily by skin manifestations to the atrophic and hypoplastic areas of skin which are present at birth. These defects manifest as yellow-pink bumps on the skin and pigmentation changes.[2] The disorder is also associated with shortness of stature and some evidence suggests that it can cause epilepsy.[3]

Genetics[edit]

The molecular Location of the PORCN gene on the X chromosome: base pairs 48,367,346 to 48,379,201

Focal dermal hypoplasia has been associated with PORCN gene mutations on the X chromosome.[4] This results in 90% of the individuals who affected with the syndrome being female. The 10% of males that have a mosaic and/or heterozygous for mutations in PORCN. The commonly accepted, though unconfirmed, explanation for most of the affected individuals being women is that the non-mosaic hemizygous males are not viable.[5]

The differential diagnosis of focal dermal hypoplasia (Goltz) syndrome includes autosomal recessive Setleis syndrome due to TWIST2 gene mutations. It associated with morning glory anomaly, polymicrogyria, incontinentia pigmenti, oculocerebrocutaneous syndrome, Rothmund-Thomson syndrome and microphthalmia with linear skin defects (also known as MLS) syndrome because they are all caused by deletions or point mutations in the HCCS gene.[6]

Origin of eponyms[edit]

Jessner-Cole syndrome[edit]

The disorder was first formally recognized by dermatologists, Max Jessner and Harold Newton Cole, in the early 20th century. Jessner and Cole's papers were referenced more than any others in the first half of the 20th century.[7][8]

Goltz-Gorlin[edit]

Besides its formal name, it is most commonly referred to as Goltz-Gorlin syndrome, after Robert Goltz and Robert Gorlin.[9] Goltz and Gorlin worked together at Columbia University [10] and are credited for describing the symptoms of the disorder in more detail than ever before and tracking its genetic trends. The name became popular during the second half of the 20th century.

See also[edit]

References[edit]

  1. ^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology (10th ed.). Saunders. ISBN 0-7216-2921-0. 
  2. ^ Goltz RW, Henderson RR, Hitch JM, Ott JE. (2008). Focal dermal hypoplasia syndrome. A review of the literature and report of two cases. GeneReviews. 
  3. ^ Kanemura H, Hatakeyama K, Sugita K, Aihara M. (2011). Epilepsy in a patient with focal dermal hypoplasia. Pediatric neurology. 
  4. ^ Wang X, Reid Sutton V, Omar Peraza-Llanes J, et al. (July 2007). "Mutations in X-linked PORCN, a putative regulator of Wnt signaling, cause focal dermal hypoplasia". Nat. Genet. 39 (7): 836–8. doi:10.1038/ng2057. PMID 17546030. 
  5. ^ Sutton, Reid. Veyver, Ignatia. (1970). Focal Dermal Hypoplasia. Arch Dermatol. 
  6. ^ Wimplinger I, Shaw GM, Kutsche K, et al. (Aug 2007). "HCCS loss-of-function missense mutation in a female with bilateral microphthalmia and sclerocornea: a novel gene for severe ocular malformations?". Mol Vis 13: 1475–82. PMID 17893649. 
  7. ^ Jessner: Naeviforme poikilodermieartige Hautveränderungen mit Missbildungen. Zentralblatt für Haut- und Geschlechtskrankheiten, 1928, 27: 468.
  8. ^ H. N. Cole, et al: Ectodermal and mesodermal dysplasia with osseous involvement. Archiv für Dermatologie und Syphilis, Berlin, 1941, 44: 773-788.
  9. ^ synd/1370 at Who Named It?
  10. ^ R. W. Goltz, W. C. Peterson, R. J. Gorlin, H. G. Ravits: Focal dermal hypoplasia. Archives of Dermatology, Chicago, 1962, 86: 708-717.

External links[edit]